All News
Filter News
Found 806,061 articles
-
Labs@Home™ Facilitates Outpatient Management of Kidney Transplants During COVID-19
5/21/2020
Following the launch in April 2020 of Labs@Home in response to the COVID-19 pandemic began impacting transplant patient care and the world, Transplant Genomics, Inc. ("TGI"), announce today the successful growth of TruGraf® driven by adoption of Labs@Home.
-
Can-Fite Receives Notice of Allowance for Namodenoson Patent in the Treatment of NASH & NAFLD from U.S. Patent and Trademark Office
5/21/2020
Patent allowance follows compelling Phase II data showing Namodenoson resolved all cases of NASH after 12 weeks of treatment, and it reduced hepatic fibrosis and steatosis in NAFLD and NASH patients
-
Scientists Use Virtual Reality to Refine New AI-Generated Drugs for COVID-19
5/21/2020
Nanome, Inc., a virtual reality (VR) startup whose signature product is a computational chemistry software platform, has co-authored a paper describing 10 potential small molecule inhibitors targeting the SARS-CoV-2 main protease that were generated by artificial intelligence (AI)
-
Resuming Restorative Surgery: Prioritizing Orthopaedic Surgery Nationwide
5/21/2020
As the COVID-19 pandemic stabilizes and hospitals begin to plan for surgeries that have been postponed, surgeons and decision makers will face ongoing challenges in prioritizing care until our health-care system is fully re-opened.
-
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 21, 2020
5/21/2020
Geron Corporation reported that it has granted a non-statutory stock option to purchase an aggregate of 70,000 shares of Geron common stock as an inducement to a newly-hired employee in connection with commencement of employment with the Company.
-
Invacare Declares Quarterly Dividend - May 21, 2020
5/21/2020
Invacare Corporation announced that its Board of Directors decided to suspend the quarterly dividend on common shares of the Company, in light of the impacts of COVID-19 on the business.
-
Vayyar partners with Meditemi to detect early stage COVID-19 symptoms in under 10 seconds
5/21/2020
The solution will be used to soften social distancing, restore public confidence in the workplace and care for people in homes.
-
PPD, Inc. Announces Pricing and Upsizing of Senior Notes Offering
5/21/2020
PPD, Inc., a leading global contract research organization, announced that Jaguar Holding Company II and PPD Development, L.P., both indirect wholly owned subsidiaries of the Company, successfully upsized and finalized the terms of the Co-Issuers’ offering of $500 million aggregate principal amount of 4.625% senior notes due 2025 and $700 million aggregate principal amount 5.000% senior notes due 2028.
-
Medtronic Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Announces Dividend Increase
5/21/2020
Medtronic plc announced financial results for its fourth quarter and fiscal year 2020, which ended April 24, 2020.
-
ChromaDex Chief Scientific Advisor Dr. Charles Brenner Receives 2020 National Scientific Achievement Award from the American Society for Nutrition
5/21/2020
ChromaDex Corp. announced Dr. Charles Brenner, the Roy J. Carver Chair and Head of Biochemistry at the University of Iowa and ChromaDex Chief Scientific Advisor, was named the 2020 recipient of the Mary Swartz Rose Senior Investigator Award from the American Society for Nutrition and its Foundation.
-
Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering - May 21, 2020
5/21/2020
Teleflex Incorporated announced that it priced its private offering of $500.0 million aggregate principal amount of 4.25% senior notes due 2028 at an issue price of 100.000%.
-
Option Care Health Selected as Preferred Pharmacy Partner To Prepare and Distribute Breakthrough Cancer Therapy
5/21/2020
Option Care Health, Inc., the nation’s largest independent provider of home and alternate site infusion services, has been selected by UroGen Pharma as a preferred national pharmacy provider to prepare and deliver a first-of-its-kind cancer treatment, Jelmyto™ for pyelocalyceal solution.
-
City of Hope Physicians/Scientists Lead Multiple, Innovative COVID-19 Research Projects
5/21/2020
Chimeric antigen receptor (CAR)-NK cell therapy to treat the virus is one of more than two dozen COVID-19 research projects underway
-
UniPath Offers COVID-19 Testing to Colorado Employers
5/21/2020
UniPath, a Colorado-based provider of subspecialty pathology, clinical and molecular testing services, is now offering COVID-19 testing to employers anxious to safely get their workers back on the job.
-
Kaiser Permanente Releases COVID-19 Playbook to Help Businesses Plan for the Future
5/21/2020
'Planning for the Next Normal at Work' provides guidance around health considerations for returning to the workplace [21-May-2020] OAKLAND, Calif. , May 21, 2020 /PRNewswire/ -- Kaiser Permanente has released a playbook, "Planning for the Next Normal at Work," to guide employers and businesses through health considerations they will need to address as they safeguard w
-
Entera Bio Ltd Announces Interim Biomarker Data From Phase 2 Clinical Trial of EB613 and First Quarter 2020 Financial Results
5/21/2020
Statistically Significant One Month Increases in P1NP Biomarker from First 50% of Patients with Highest Dose of EB613
-
Castlight Health Teams Up with New York State Department of Health to Launch Statewide COVID-19 Test Site Directory
5/21/2020
Castlight Health, Inc. announced a partnership with the New York State Department of Health to launch a statewide directory of COVID-19 test sites.
-
Mentice Expands its Coronary Product Portfolio With an Advanced Software Solution for Coronary Interventions
5/21/2020
Coronary Advanced to Help Fellows and Attending Interventional Cardiologists to Perfect Skills in Complex Scenarios
-
Switch Health Launches First Mobile Rapid Testing Unit (MRTU) to Fight COVID-19 in Canada
5/21/2020
May 21, 2020, Switch Health Holdings Inc. is pleased to announce the launch of its first Mobile Rapid Testing Unit, designed to assist in the fight against COVID-19.
-
Atomwise Partners with Global Research Teams to Pursue Broad-Spectrum Treatments Against COVID-19 and Future Coronavirus Outbreaks
5/21/2020
Atomwise democratizes access to its advanced AI technology with 15 research collaborations underway to enable academic researchers to discover novel therapies for this pandemic and those in the future.